GLIMESTAR PM 2

Glimestar-PM2 is an extended-release tablet designed to assist in regulating blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication is intended to be used in conjunction with a balanced diet and regular physical activity to enhance glycemic control. By facilitating the effective use of insulin, Glimestar-PM2 helps to lower blood sugar levels, thereby contributing to better overall health management for those affected by this condition. It is crucial to adhere strictly to the dosage and duration recommended by your healthcare provider. To mitigate potential stomach discomfort, it is advised to consume this medication with food. In instances where a dose is missed, it should be taken as soon as you remember. However, if the time for the next scheduled dose is near, it is advisable to skip the missed dose without doubling up. Overdosing on this medication can result in hypoglycemia, a condition characterized by abnormally low blood sugar levels. Individuals taking Glimestar-PM2 alongside other antidiabetic medications, alcohol, or who miss meals may be at higher risk for developing hypoglycemia. Therefore, it is important to regularly monitor your blood sugar while on this treatment. Some commonly reported side effects include nausea, diarrhea, abdominal pain, headaches, increased risk of bone fractures, and respiratory infections. Prior to commencing treatment with Glimestar-PM2, it is essential to notify your healthcare provider about any pre-existing kidney, liver, or heart issues. Pregnant or nursing individuals should also seek medical advice before initiating therapy with this medication. Your doctor may conduct kidney function tests before starting treatment to ensure your safety.